SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apples quarterly earnings are driving attention: the company beat expectations, led by iPhone and Mac sales, but the stocks muted-to-negative reaction reflects debate over whether the results and outlook justify its valuation. Traders are focused on weaker China, iPad and wearables results, tariff-boosted margins, and rising memory costs, while bulls point to the strong core-device performance.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantirs Q3 results dominate discussion: the company beat expectations, raised its outlook, and reported rapid U.S. commercial growth that surpassed government revenue. Traders remain divided over the muted share-price reaction, with some citing a rich valuation and sell-the-news pressure while bulls emphasize the growth and guidance.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLASs Phase 3 REGAL trial reaching its prespecified 80th event triggered final analysis, putting results for its GPS treatment in focus. The sharp selloff has traders debating profit-taking and risk reduction ahead of a binary readout versus unverified fears of a negative leak or short-driven pressure; no trial outcome is established.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMDs upcoming quarterly earnings are drawing attention as traders weigh whether Intels weak report signals broader chip-market trouble or company-specific issues. The sharp selloff has fueled concern about further losses and high valuation, while bulls argue AMDs growth and a strong earnings outlook could distinguish it from Intel and support a rebound.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracles planned stock and bond offerings to fund its AI infrastructure buildout have fueled the selloff, with traders worried about dilution, rising debt and whether the spending will generate returns. Others argue the financing was already outlined and could secure the funding needed for growth, but confidence in management and the AI payoff remains sharply divided.

Aehr Test Systems engages in the design, manufacture, market, and sale of test and burn-in equipment used in the semiconductor industry. Its products include FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer contactor, the DiePak Carrier, the WaferPak Aligner, the DiePak Autoloader, and test fixtures. The company was founded by Rhea J. Posedel on May 25, 1977 and is headquartered in Fremont, CA.

Aehr Test Systems

Aehrs fiscal Q1 report beat expectations and raised its FY27 revenue outlook, reinforcing the AI chip-testing growth story. Traders welcomed the results but debated the stocks steep decline despite the strong report, citing valuation concerns and broader market weakness.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is drawing attention amid a sharp tech- and AI-led selloff, with traders questioning whether heavy AI infrastructure spending and financing will generate adequate returns. The discussion is largely bearish, though some see oversold conditions and the 200-day average as possible support; midterm uncertainty and Apples results add to the debate.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

A report that nonprofit Usona may have filed an FDA application for psilocybin in major depressive disorder has sparked fears of competition and a first-to-market setback for CMPS, contributing to a sharp selloff. Traders dispute whether the filing is confirmed and note that Compass is developing COMP360 for treatment-resistant depression; many view the reaction as an overreaction while awaiting managements update on its NDA timeline.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

A sharp semiconductor and tech-sector selloff, fueled by fears that heavy AI spending may not pay off and by broader risk-off trading, has put pressure on SOXL. Traders are split between calling the decline a buying opportunity and expecting further losses, with many noting that the funds 3 leverage magnifies the moves and can erode returns when held through volatility.

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It operates through the following segments: Commercial Product Sales, MCM Product Sales, and Services. The Commercial Product Sales segment includes NARCAN products and other commercial products that were sold as part of the travel health business. The MCM Product Sales segment focuses on the Anthrax - MCM products, Smallpox - MCM products and other products. The Services segment consists of the company’s Bioservices offerings. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.

Emergent Biosolutions Inc

Emergents Q3 results and lower full-year outlook are driving discussion, with traders focused on falling revenue, weak NARCAN sales, and uncertain timing of government orders. Many are frustrated by repeated forecast cuts and worry about debt and refinancing, while some see potential in cost savings and future CYFENDUS procurement.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$ABCL There&#39;s no way to spin being down almost -9% on the day with zero reasoning! Stupid ass mid terms need to hurry tf up already! For those of you that need more shares then it&#39;s a fantastic day I suppose, I don&#39;t need more, I would prefer my invest go up, not down!

The Legendary Mayor

TM Underhill

StockTwits Web

AbCellera Biologics Inc

 There's no way to spin being down almost -9% on the day with zero reasoning! Stupid ass mid terms need to hurry tf up already! For those of you that need more shares then it's a fantastic day I suppose, I don't need more, I would prefer my invest go up, not down!